Wells Fargo & Company HALOZYME THERAPEUTICS INC Transaction History

Wells Fargo & Company

14,342,000

Previous 9,435,000 52.01%

Previous $0 NaN%

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	N/A	4,907,000 Added 52.01%	14,342,000 $0
Q1 2025 May 13, 2025	BUY	N/A	4,090,000 Added 76.52%	9,435,000 $0
Q4 2024 Feb 12, 2025	SELL	N/A	-11,490,000 Reduced 68.25%	5,345,000 $0
Q3 2024 Nov 13, 2024	BUY	N/A	3,821,000 Added 29.36%	16,835,000 $0
Q2 2024 Aug 13, 2024	BUY	N/A	5,018,000 Added 62.76%	13,014,000 $0
Q1 2024 May 10, 2024	BUY	N/A	4,633,000 Added 137.76%	7,996,000 $0
Q4 2023 Feb 09, 2024	SELL	N/A	-130,000 Reduced 3.72%	3,363,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	3,493,000 New	3,493,000 $0

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.